Search Results - "Kohlhaw, K"

Refine Results
  1. 1

    Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival by Berr, Frieder, Wiedmann, Marcus, Tannapfel, Andrea, Halm, Ulrich, Kohlhaw, Kay R., Schmidt, Frank, Wittekind, Christian, Hauss, Johann, Mössner, Joachim

    Published in Hepatology (Baltimore, Md.) (01-02-2000)
    “…Median survival time of nonresectable hilar bile duct cancer is only 4 to 6 months owing to tumor spread in the biliary tree, refractory cholestasis, and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus by Lohmann, T, List, C, Lamesch, P, Kohlhaw, K, Wenzke, M, Schwarz, C, Richter, O, Hauss, J, Seissler, J

    “…The induction of diabetes has been recognised as adverse effect of the immunsuppressive drug FK506/Tacrolimus. The aim of this study was to clarify whether…”
    Get more information
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Cyclosporine monitoring in liver allograft recipients: two distinct patterns of blood level derangement associated with nephrotoxicity by Wonigeit, K, Kohlhaw, K, Winkler, M, Schaefer, O, Pichlmayr, R

    Published in Transplantation proceedings (01-06-1990)
    “…The parallel measurement of specific and nonspecific CyA levels by second generation radioimmunoassays based on monoclonal antibodies proved to be an effective…”
    Get more information
    Journal Article
  10. 10

    Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study by Wiedmann, Marcus, Berr, Frieder, Schiefke, Ingolf, Witzigmann, Helmut, Kohlhaw, Kay, Mössner, Joachim, Caca, Karel

    Published in Gastrointestinal endoscopy (01-07-2004)
    “…Median survival of patients with non-resectable hilar cholangiocarcinoma is 3 to 6 months, even after biliary drainage. Therefore, a single-arm phase II study…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Serum bile acids and esterified bilirubin in early detection and differential diagnosis of hepatic dysfunction following orthotopic liver transplantation by Muraca, M, Kohlhaw, K, Vilei, M T, Ringe, B, Bunzendahl, H, Gubernatis, G, Wonigeit, K, Brunner, G, Pichlmayr, R

    Published in Journal of hepatology (01-02-1993)
    “…Routine laboratory tests are of little help for early detection and differential diagnosis of hepatic dysfunction following orthotopic liver transplantation…”
    Get more information
    Journal Article
  13. 13

    Ciclosporin metabolite pattern in blood and urine of liver graft recipients. I. Association of ciclosporin metabolites with nephrotoxicity by Christians, U, Kohlhaw, K, Budniak, J, Bleck, J S, Schottmann, R, Schlitt, H J, Almeida, V M, Deters, M, Wonigeit, K, Pichlmayr, R

    Published in European journal of clinical pharmacology (01-10-1991)
    “…Blood ciclosporin (Cs) metabolite pattern in 58 liver grafted patients was routinely monitored by HPLC from the first Cs dose after transplantation until…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Investigations on the metabolic pathways of cyclosporine: II. Elucidation of the metabolic pathways in vitro by human liver microsomes by Christians, U, Strohmeyer, S, Kownatzki, R, Schiebel, H M, Bleck, J, Kohlhaw, K, Schottmann, R, Sewing, K F

    Published in Xenobiotica (1991)
    “…1. Cyclosporine and its metabolites, isolated from human bile and identified by FAB mass spectrometry and 1H-n.m.r. spectroscopy, were metabolized by human…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20